Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Faster, Cleaner, Better.

Vyne Therapeutics Inc (VYNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2016
Assets
Current Assets
Cash & Cash Equivalents	58,418	44,584	49,510	10,206	4,027
Marketable Securities	1,027	28,782	86,740	49,295	26,881
Receivables	15,819	135	N/A	786	N/A
Inventories	7,404	1,356	N/A	N/A	N/A
TOTAL	$87,259	$76,414	$139,500	$63,861	$31,540

Non-Current Assets
PPE Net	555	2,885	146	28	27
Investments And Advances	0	0	0	2,978	10,420
Other Non-Current Assets	5,928	1,860	282	0	66
TOTAL	$6,483	$4,745	$428	$3,006	$10,513

Total Assets	$93,742	$81,159	$139,928	$66,867	$42,053

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	4,780	19,352	3,290	2,462	1,526
Accrued Expenses	11,452	3,381	6,254	3,559	581
Other current liabilities	4,776	5,501	N/A	N/A	N/A
TOTAL	$21,765	$29,326	$9,544	$7,817	$3,903

Non-Current Liabilities
Long Term Debt	33,174	32,725	N/A	N/A	N/A
Deferred Revenues	N/A	N/A	N/A	1,796	1,796
Other Non-Current Liabilities	1,310	1,533	7	22	57
TOTAL	$34,484	$34,258	$7	$6,757	$8,588

Total Liabilities	$56,249	$63,584	$9,551	$14,574	$12,491

Shareholders' Equity
Shares Outstanding, K	2,854	340	323	N/A	N/A
Common Shares	4	1	3	1	1
Retained earnings	-566,196	-310,587	-110,636	-59,191	-30,115
Other shareholders' equity	0	5	-96	109,276	58,977
TOTAL	$37,493	$17,575	$130,377	$52,293	$29,562

Total Liabilities And Equity	$93,742	$81,159	$139,928	$66,867	$42,053